logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Etubics Corporation

Calculating rank
USPTO Granted Patents = 19


Forward Citations = 68

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Frank R Jones (19 out of 26 patents)

silverMedal Joseph P Balint (14 out of 24 patents)

bronzeMedal Elizabeth Gabitzsch (10 out of 10 patents)

4.  Richard B Gayle (6 out of 6 patents)

5.  Yvette Latchman (6 out of 7 patents)

6.  Adrian Rice (6 out of 6 patents)

7.  Richard B Gayle, Iii (3 out of 6 patents)

8.  Richard B Iii Gayle (0 patent)

9.  Richard B Iii Gayle (0 patent)


19 patents:

1. 12370250 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2025-07-29),
2. 11826417 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2023-11-28),
3. 11529408 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-12-20),
4. 11504423 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-11-22),
5. 11389521 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-07-19),
6. 11376316 - Breast cancer vaccines and methods of use thereof (2022-07-05),
7. 11369673 - HPV vaccines and methods of use thereof (2022-06-28),
8. 11352642 - Methods and compositions for combination immunotherapy (2022-06-07),
9. 11344613 - Sequential administration of a replication defective adenovirus vector in vaccination protocols (2022-05-31),
10. 11304998 - Combination immunotherapies comprising IL-15 superagonists (2022-04-19),
11. 11149087 - Methods and compositions for combination immunotherapy (2021-10-19),
12. 11116827 - Compositions and methods for tumor vaccination and immunotherapy involving HER antigens (2021-09-14),
13. 11104916 - Compositions and methods for alphavirus vaccination (2021-08-31),
14. 11020467 - Combination immunotherapies comprising IL-15 superagonists (2021-06-01),
15. 10835596 - Compositions and methods for flavivirus vaccination (2020-11-17),
Company Overview
Etubics Corporation, based in Seattle, WA, specializes in the development of innovative biopharmaceutical solutions. The company focuses on advancing therapeutic technologies, particularly in the fields of immunotherapy and regenerative medicine. By leveraging cutting-edge research, Etubics aims to address significant medical challenges and improve patient outcomes. Their commitment to scientific excellence positions them as a key player in the evolving landscape of healthcare and biotechnology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

19 Patents

#107 in Seattle, WA

#373 in Washington

#17,154 in US

#32,705 in the World

Seattle, WA (US)
Seattle, WA, United States of America

Etubics Corporation

Forward Citations = 68

7 inventors:

goldMedal Frank R Jones (19 out of 26 patents)

silverMedal Joseph P Balint (14 out of 24 patents)

bronzeMedal Elizabeth Gabitzsch (10 out of 10 patents)

4.  Richard B Gayle (6 out of 6 patents)

5.  Yvette Latchman (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Etubics Corporation. Retrieved from https://idiyas.com/company/etubics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…